Capnia Inc (NASDAQ:CAPN) was the target of a large growth in short interest in March. As of March 31st, there was short interest totalling 226,586 shares, a growth of 9.0% from the March 15th total of 207,961 shares. Based on an average trading volume of 36,279 shares, the days-to-cover ratio is currently 6.2 days.
Separately, Maxim Group set a $5.00 price objective on Capnia and gave the company a “buy” rating in a research report on Saturday, March 11th.
An institutional investor recently raised its position in Capnia stock. Sabby Management LLC increased its position in shares of Capnia Inc (NASDAQ:CAPN) by 30.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 233,938 shares of the company’s stock after buying an additional 54,936 shares during the period. Sabby Management LLC owned about 0.49% of Capnia worth $159,000 as of its most recent SEC filing. 45.67% of the stock is owned by institutional investors.
Capnia (NASDAQ:CAPN) opened at 0.70 on Friday. Capnia has a 12-month low of $0.55 and a 12-month high of $1.57. The company’s market capitalization is $33.24 million. The stock’s 50 day moving average price is $0.64 and its 200 day moving average price is $0.80.
Capnia (NASDAQ:CAPN) last posted its earnings results on Thursday, May 11th. The company reported ($0.11) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.07) by $0.04. The business had revenue of $0.27 million for the quarter. Capnia had a negative net margin of 872.75% and a negative return on equity of 283.18%. On average, equities analysts anticipate that Capnia will post ($0.31) EPS for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: This piece of content was first published by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The legal version of this piece of content can be viewed at https://sportsperspectives.com/2017/05/20/capnia-inc-capn-sees-significant-growth-in-short-interest-updated-updated-updated.html.
Capnia Company Profile
Capnia, Inc is a United States-based healthcare company that develops and commercializes neonatology devices and diagnostics. The Company also has a therapeutics platform based on its proprietary technology for precision metering of gas flow. The Company offers products, such as CoSense end-tidal carbon monoxide (ETCO) Monitor, NeoPIP Infant Resuscitator and Accessories, and Serenz Nasal Relief.
Receive News & Ratings for Capnia Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Capnia Inc and related companies with MarketBeat.com's FREE daily email newsletter.